Shruti Kate

専門分野: Clinical oncologist
15年の経験
話します:
English, Hindi
オンラインコンサルテーション：利用可能
勤務先: インド, ナーシク, HCG Manavata Cancer Centre
Qualification : MD DM (Medical Oncology) Designation : HOD, Consultant Services Offered : Chemotherapy
Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.

Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.

Shruti Kateとのオンラインコンサルテーション

便利で簡単

100%安全で機密

お問い合わせください

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Dr. Shruti Kate is one of the best oncologists treating different cancer types. She manages conservative and surgical treatment, including a Whipple procedure. Dr. Shruti Kate did her MBBS from the prestigious Lady Hardinge Medical College (2003- 2008), Delhi and MD internal medicine from Maulana Azad Medical College (2010-2013), Delhi. She pursued DM Medical Oncology from Tata Memorial Hospital, Mumbai (2013-2016) and prior to joining HCG Manavata Cancer Centre, she was working in Tata Memorial Hospital as a consultant in the department of medical oncology.

Dr. Shruti Kate has received training under the able guidance of stalwarts of medical oncology and is experienced in treating all solid tumors, pediatric tumors and hematological malignancies. She is a member of reputed international and national oncological societies (ASCO, ESMO, IASCLC ,ISMPO and IOS). She has an expertise in treating lung cancer, breast cancer, gynecological and genitourinary cancers. She has a deep interest in immunotherapy and metronomic therapy for treatment of advanced cancers. She has presented her research on lung cancer in the World Conference on Lung Cancer (WCLC) in Toronto, Canada and was the solo recipient of travel award from India in WCLC 2018.